← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Future Oncology (ISSN 1744-8301, 1479-6694) is a journal published by Taylor & Francis in the United Kingdom. It covers Biochemistry, Genetics and Molecular Biology, Medicine and Medicine (miscellaneous). It is indexed in Scopus, Web of Science, PubMed and HEC. Recorded metrics: impact factor 3.1, Scopus Q2, Web of Science Q2, CiteScore 4.9 and HEC W-Category. Article processing charge: USD 3,095.53. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Future Oncology

ISSN
1744-8301, 1479-6694
Subject area
BiochemistryGenetics and Molecular BiologyMedicineMedicine (miscellaneous)OncologyCancer Research
Indexed
ScopusWeb of SciencePubMedHEC
Scopus Quartile
Q2
WoS Quartile
Q2
Impact Factor
3.1
Country
United Kingdom
Publisher
Taylor & Francis
SJR
1.229
Open access
No
APC (USD)
3095.53
About the journal
Future Oncology focuses on significant advancements in cancer research and highlights their relevance in a clinical setting. The journal provides comprehensive coverage of cancer treatments, diagnostics, and clinical trials, in addition to in-depth evaluations of newly approved drugs and medical devices. This key information is delivered in concise, at-a-glance article formats. To help patients, advocates, and the wider public engage with the latest developments, the journal publishes Plain Language Summaries as standalone articles and as abstracts integrated into original research publications. Beyond clinical advancements, Future Oncology addresses real-world challenges, economic considerations, and policy issues in oncology. It also features perspective articles from clinicians and experts, providing analysis and informed opinions on treatment approaches.
Aims and Scope
Future Oncology focuses on significant advancements in cancer research and highlights their relevance in a clinical setting. The journal provides comprehensive coverage of cancer treatments, diagnostics, and clinical trials, in addition to in-depth evaluations of newly approved drugs and medical devices. This key information is delivered in concise, at-a-glance article formats. To help patients, advocates, and the wider public engage with the latest developments, the journal publishes Plain Language Summaries as standalone articles and as abstracts integrated into original research publications. Beyond clinical advancements, Future Oncology addresses real-world challenges, economic considerations, and policy issues in oncology. It also features perspective articles from clinicians and experts, providing analysis and informed opinions on treatment approaches. Topics include new anticancer agents and novel treatment combinations; protocols of ongoing studies; targeted and personalized approaches; clinical implications and applications of immunotherapies, radiotherapies, and biomarkers; integration of diagnostic and therapeutic approaches, including AI-driven diagnostics to support clinical decision-making; the impact of molecular genetics on cancer prevention, screening, diagnosis, and treatment; screening programs and methodology; biological processes involved in cancer and how new understanding may affect treatment; policy and treatment-guideline debates, including expert perspectives; and real-world data and outcomes research.
Journal Website
Journal Website Direct Link ↗
Instructions for Authors URL
Journal's Author Direct Link ↗
Scopus URL
Scopus Direct Link ↗
APC Information URL
APC Information Direct Link ↗
WoS URL
Web of Science Direct Link ↗
SCImago Ranking
3490
HEC
W-Category
Registered In
2005
Average Time To Publication After Submission (In Weeks)
—
Waiver policy
—
Scopus Cite Score
4.9
WoS Status
Science Citation Index Expanded (SCIE)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Future Oncology

Is Future Oncology HEC recognised?

Yes. The catalogue records Future Oncology in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Future Oncology indexed in Scopus?

Yes. Future Oncology is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 4.9. Check its current status on the Scopus Sources page.

Is Future Oncology in Web of Science?

Yes. Future Oncology is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.

What is the impact factor of Future Oncology?

The recorded journal impact factor of Future Oncology is 3.1. Clarivate updates impact factors every year in Journal Citation Reports.

Is Future Oncology open access, and what does it charge?

Future Oncology is not recorded as fully open access and its APC is USD 3,095.53. Fees change, so check the journal's website before you submit.

Who publishes Future Oncology?

Future Oncology is published by Taylor & Francis in United Kingdom, under ISSN 1744-8301 and 1479-6694.

Research profile

Main research topics: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Breast Cancer Treatment Studies, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Lung Cancer Research Studies.

Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal